Improving Transportation Assets and the Effects on Wellness Metrics (ACTiN)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05510765 |
Recruitment Status :
Not yet recruiting
First Posted : August 22, 2022
Last Update Posted : August 22, 2022
|
Sponsor:
John M. Salmon IV, MD
Information provided by (Responsible Party):
John M. Salmon IV, MD, Unified Potential, Inc.
Tracking Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
First Submitted Date ICMJE | August 10, 2022 | ||||||||||||||||||
First Posted Date ICMJE | August 22, 2022 | ||||||||||||||||||
Last Update Posted Date | August 22, 2022 | ||||||||||||||||||
Estimated Study Start Date ICMJE | October 2022 | ||||||||||||||||||
Estimated Primary Completion Date | October 2023 (Final data collection date for primary outcome measure) | ||||||||||||||||||
Current Primary Outcome Measures ICMJE |
|
||||||||||||||||||
Original Primary Outcome Measures ICMJE | Same as current | ||||||||||||||||||
Change History | No Changes Posted | ||||||||||||||||||
Current Secondary Outcome Measures ICMJE |
|
||||||||||||||||||
Original Secondary Outcome Measures ICMJE | Same as current | ||||||||||||||||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||||||||||||||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||||||||||||||||
Descriptive Information | |||||||||||||||||||
Brief Title ICMJE | Improving Transportation Assets and the Effects on Wellness Metrics | ||||||||||||||||||
Official Title ICMJE | ACTiN and Health Metrics: Improving Transportation Assets as a Critical Social Determinant of Health and the Effects on Wellness and Chronic Disease Metrics. | ||||||||||||||||||
Brief Summary |
|
||||||||||||||||||
Detailed Description |
|
||||||||||||||||||
Study Type ICMJE | Interventional | ||||||||||||||||||
Study Phase ICMJE | Not Applicable | ||||||||||||||||||
Study Design ICMJE | Allocation: N/A Intervention Model: Single Group Assignment Intervention Model Description: Prospective Masking: None (Open Label)Primary Purpose: Other |
||||||||||||||||||
Condition ICMJE | Social Determinants of Health | ||||||||||||||||||
Intervention ICMJE | Behavioral: Transportation service
Improved transportation assets applied to all aspects of subjects life
|
||||||||||||||||||
Study Arms ICMJE | Experimental: Study arm
Low resource, high risk individuals with limited transportation options as a social determinant of health.
Intervention: Behavioral: Transportation service
|
||||||||||||||||||
Publications * |
|
||||||||||||||||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||||||||||||
Recruitment Information | |||||||||||||||||||
Recruitment Status ICMJE | Not yet recruiting | ||||||||||||||||||
Estimated Enrollment ICMJE |
50 | ||||||||||||||||||
Original Estimated Enrollment ICMJE | Same as current | ||||||||||||||||||
Estimated Study Completion Date ICMJE | January 2024 | ||||||||||||||||||
Estimated Primary Completion Date | October 2023 (Final data collection date for primary outcome measure) | ||||||||||||||||||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||||||||||||||
Sex/Gender ICMJE |
|
||||||||||||||||||
Ages ICMJE | 18 Years and older (Adult, Older Adult) | ||||||||||||||||||
Accepts Healthy Volunteers ICMJE | Yes | ||||||||||||||||||
Contacts ICMJE |
|
||||||||||||||||||
Listed Location Countries ICMJE | United States | ||||||||||||||||||
Removed Location Countries | |||||||||||||||||||
Administrative Information | |||||||||||||||||||
NCT Number ICMJE | NCT05510765 | ||||||||||||||||||
Other Study ID Numbers ICMJE | 4212.081022 | ||||||||||||||||||
Has Data Monitoring Committee | No | ||||||||||||||||||
U.S. FDA-regulated Product |
|
||||||||||||||||||
IPD Sharing Statement ICMJE |
|
||||||||||||||||||
Current Responsible Party | John M. Salmon IV, MD, Unified Potential, Inc. | ||||||||||||||||||
Original Responsible Party | Same as current | ||||||||||||||||||
Current Study Sponsor ICMJE | John M. Salmon IV, MD | ||||||||||||||||||
Original Study Sponsor ICMJE | Same as current | ||||||||||||||||||
Collaborators ICMJE | Not Provided | ||||||||||||||||||
Investigators ICMJE |
|
||||||||||||||||||
PRS Account | Unified Potential, Inc. | ||||||||||||||||||
Verification Date | August 2022 | ||||||||||||||||||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |